• 1
    Scheuer PJ. Primary biliary cirrhosis. In: ScheuerPJ, ed. Liver Biopsy Interpretation. 4th ed. London: Bailliere Tindall, 1988; 5365.
  • 2
    Paronetto F, Schaffner F, Popper H. Immunocytochemical and serologic observations in primary biliary cirrhosis. N Engl J Med 1964; 271: 11231128.
  • 3
    Paronetto F, Schaffner F, Popper H. Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis. J Lab Clin Med 1967; 69: 979988.
  • 4
    Galbraith RM, Smith M, Mackenzie RM, Tee DE, Doniach D, Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med 1974; 290: 6369.
  • 5
    Selmi C, Ross SR, Ansari AA, Invernizzi P, Podda M, Coppel RL, et al. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 2004; 127: 493501.
  • 6
    Xu L, Sakalian M, Shen Z, Loss G, Neuberger J, Mason A. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. HEPATOLOGY 2004; 39: 151156.
  • 7
    Metcalf JV, Bhopal RS, Gray J, Howel D, James OF. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol 1997; 26: 830836.
  • 8
    Sood S, Gow PJ, Christie JM, Angus PW. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 2004; 127: 470475.
  • 9
    Hamlyn AN, Macklon AF, James O. Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality. Gut 1983; 24: 940945.
  • 10
    Prince MI, Chetwynd A, Diggle P, Jarner M, Metcalf JV, James OF. The geographical distribution of primary biliary cirrhosis in a well-defined cohort. HEPATOLOGY 2001; 34: 10831088.
  • 11
    Invernizzi P, Miozzo M, Battezzati PM, Bianchi I, Grati FR, Simoni G, et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004; 363: 533535.
  • 12
    Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. HEPATOLOGY 2001; 33: 1621.
  • 13
    Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999; 30: 402407.
  • 14
    Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004; 127: 485492.
  • 15
    Jones DE, Donaldson PT. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 2003; 7: 841864.
  • 16
    Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994; 20: 698701.
  • 17
    Triger DR. Primary biliary cirrhosis: an epidemiological study. Br Med J 1980; 281: 772775.
  • 18
    Kita H, He XS, Gershwin ME. Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis. Ann Med 2004; 36: 7280.
  • 19
    Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, et al. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol 2004; 172: 64446452.
  • 20
    Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. HEPATOLOGY 2003; 38: 12501257.
  • 21
    Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005; 174: 58745883.
  • 22
    Annual Report of the Inactive Hazardous Waste Disposal Sites in New York. New York State Department of Environmental Conservation, Division of Environmental Remediation, 2002.
  • 23
    Vine MF, Stein L, Weigle K, Schroeder J, Degnan D, Tse CK, et al. Effects on the immune system associated with living near a pesticide dump site. Environ Health Perspect 2000; 108: 11131124.
  • 24
    Carpenter DO, Shen Y, Nguyen T, Liniger LL. Incidence of endocrine disease among residents of New York areas of concern. Environ Health Perspect 2001; 109( Suppl 6): 845851.
  • 25
    Kulldorff M. SaTScan: software for the spatial and space-time scan statistics. Version 4.0. Rockville, MD: Information Management Services, Inc., 2004.
  • 26
    D'Aignaux JH, Cousens SN, Delasnerie-Laupretre N, Brandel JP, Salomon D, Laplanche JL, et al. Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. Int J Epidemiol 2002; 31: 490495.
  • 27
    Le CT, Boen JR. Health and Numbers. Basic Biostatistical Methods. New York: A John Wiley & Sons Inc., 1995.
  • 28
    Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA, et al. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 2000; 6: 489494.
  • 29
    Liermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. HEPATOLOGY 2001; 33: 2227.
  • 30
    Yang R. NTP technical report on the toxicity studies of a Chemical Mixture of 25 Groundwater Contaminants Administered in Drinking Water to F344/N Rats and B6C3F(1) Mice. Toxic Rep Ser 1993; 35: 1I12.
  • 31
    Vezina CM, Walker NJ, Olson JR. Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression. Environ Health Perspect 2004; 112: 16361644.
  • 32
    Suh J, Kang JS, Yang KH, Kaminski NE. Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls. Toxicol Appl Pharmacol 2003; 187: 1121.
  • 33
    Chen S, Nguyen N, Tamura K, Karin M, Tukey RH. The role of the Ah receptor and p38 in benzo[a]pyrene-7,8-dihydrodiol and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced apoptosis. J Biol Chem 2003; 278: 1952619533.
  • 34
    Mato TK, Davis PA, Odin JA, Coppel RL, Gershwin ME. Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. HEPATOLOGY 2004; 40: 12411248.
  • 35
    Kanz MF, Kaphalia L, Mohsin S, Taj Z, Moslen MT. Hyperthyroidism increases covalent binding and biliary excretion of 1,1-dichloroethylene in rats. J Toxicol Environ Health 1994; 41: 187206.
  • 36
    Howel D, Fischbacher CM, Bhopal RS, Gray J, Metcalf JV, James OF. An exploratory population-based case-control study of primary biliary cirrhosis. HEPATOLOGY 2000; 31: 10551060.
  • 37
    Verma Y, Rana SV. Gender differences in the metabolism of benzene, toluene and trichloroethylene in rat with special reference to certain biochemical parameters. J Environ Biol 2003; 24: 135140.
  • 38
    Albright JF, Goldstein RA. Airborne pollutants and the immune system. Otolaryngol Head Neck Surg 1996; 114: 232238.
  • 39
    Brandao MM, Rego MA, Pugliese L, Clarencio J, Bastos CM, Ferreira J, et al. Phenotype analysis of lymphocytes of workers with chronic benzene poisoning. Immunol Lett 2005; 101: 6570.
  • 40
    Brown EA, Shelley ML, Fisher JW. A pharmacokinetic study of occupational and environmental benzene exposure with regard to gender. Risk Anal 1998; 18: 205213.
  • 41
    Sapkota A, Williams D, Buckley TJ. Tollbooth workers and mobile source-related hazardous air pollutants: how protective is the indoor environment? Environ Sci Technol 2005; 39: 29362943.
  • 42
    Krieger N, Waterman P, Chen JT, Soobader MJ, Subramanian SV, Carson R. Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas—the Public Health Disparities Geocoding Project. Am J Public Health 2002; 92: 11001102.